Relay Therapeutics, Inc. RLAY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$73.29M+4.9% | -$54.89M+27.8% | -$74.15M+15.8% | -$70.38M+23.7% | -$77.07M+5.3% | ||
| $504K-58.3% | $599K-55.1% | $748K-45.3% | $1M-26.8% | $1.21M-13.4% | ||
| $10.54M-45.5% | $13.07M-25.9% | $15.53M-30.9% | $14.5M-46.0% | $19.33M-28.9% | ||
| -$51.11M+30.2% | -$44.87M+22.5% | -$62.12M+17.3% | -$55.26M+16.1% | -$73.21M-45.5% | ||
| —— | $1K— | $0-100% | $26K+136% | $384K-78.4% | ||
| $32.9M-22.5% | $35.46M— | $39.73M+131% | $75.15M+65.0% | $42.47M+303% | ||
| $138.78M— | $934K+16.8% | $17K-100.0% | —— | —— | ||
| $120.57M+492% | -$8.47M+69.8% | -$22.38M-227% | —— | -$30.75M-437% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Relay Therapeutics, Inc. generate?
- Relay Therapeutics, Inc. (RLAY) generated -$213.4M in operating cash flow over the trailing twelve months.
- Where does Relay Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
